BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6243596)

  • 1. Recurrence of metastatic trophoblastic disease after negative, plasma human chorionic gonadotropin beta-subunit assay.
    McComb P; Ho Yuen B; Boyes D; White G
    Gynecol Oncol; 1980 Feb; 9(1):114-6. PubMed ID: 6243596
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical use of human chorionic gonadotropin in the treatment of trophoblastic neoplasia].
    Cohen AD; Piura B
    Harefuah; 1996 Nov; 131(9):348-52. PubMed ID: 8981809
    [No Abstract]   [Full Text] [Related]  

  • 3. Late recurrence of gestational trophoblastic disease.
    Jones WB; Lewis JL
    Gynecol Oncol; 1985 Jan; 20(1):83-91. PubMed ID: 2981192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
    Cole LA; Kohorn EI; Kim GS
    J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum methotrexate and human chorionic gonadotropin concentrations during five-day chemotherapy for low-risk metastatic gestational trophoblastic neoplasia.
    Hilgers RD; Standefer JC; Bowling MC; Greeley P
    Int J Gynaecol Obstet; 1988 Dec; 27(3):421-5. PubMed ID: 2904909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB; Lehr M; Lewis JL
    Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
    Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
    Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The kinetics of chorionic gonadotropin and its subunits in normal pregnancy and gestational trophoblastic neoplasms].
    Kunhardt J; Calderón J; Rodríguez S; Fletcher P; Ayala A; Reyes V
    Ginecol Obstet Mex; 1987 Jul; 55():188-91. PubMed ID: 2484840
    [No Abstract]   [Full Text] [Related]  

  • 10. Hook effect in immunoradiometric assay for human chorionic gonadotropine as a marker for trophoblastic disease.
    Fignon A; Guilloteau D; Lansac J; Besnard JC
    Eur J Obstet Gynecol Reprod Biol; 1995 Aug; 61(2):183-4. PubMed ID: 7556846
    [No Abstract]   [Full Text] [Related]  

  • 11. Human chorionic gonadotropin, its free subunits and gestational trophoblastic disease.
    Ozturk M
    J Reprod Med; 1991 Jan; 36(1):21-6. PubMed ID: 1706779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical aspects and therapy of trophoblastic tumors].
    Ziegenhagen DJ; Wolff F; Kusche M; Bolte A
    Dtsch Med Wochenschr; 1985 Mar; 110(13):499-503. PubMed ID: 2983967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy beta1 glycoprotein and chorionic gonadotrophin in the serum of patients with trophoblastic and non-trophoblastic tumours.
    Bagshawe KD; Lequin RM; Sizaret PH
    Eur J Cancer (1965); 1978 Dec; 14(12):1331-5. PubMed ID: 83941
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of metastatic trophoblastic disease with poor prognosis.
    Surwit EA; Hammond CB
    Obstet Gynecol; 1980 May; 55(5):565-70. PubMed ID: 6245395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medroxyprogesterone acetate in non-metastatic gestational trophoblastic disease.
    Goldberg GL; Cloete K; Bloch B; Wiswedel K; Altaras MM
    Br J Obstet Gynaecol; 1987 Jan; 94(1):22-5. PubMed ID: 2434125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated hCG and a high proportion of hCGbeta in serum preceding the diagnosis of trophoblastic disease by seven months.
    Vartiainen J; Alfthan H; Lehtovirta P; Stenman UH
    BJOG; 2002 May; 109(5):589-90. PubMed ID: 12066956
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory assessment of disappearance patterns of human chorionic gonadotropin from serum of patients with gestational trophoblastic disease.
    Boots LR; Hatch KD; Younger JB
    Ala J Med Sci; 1983 Oct; 20(4):391-4. PubMed ID: 6316799
    [No Abstract]   [Full Text] [Related]  

  • 18. Human chorionic gonadotropin assays and their uses.
    Tyrey L
    Obstet Gynecol Clin North Am; 1988 Sep; 15(3):457-75. PubMed ID: 2852329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperthyroxinemia in trophoblastic disease].
    Cano C; MacGregor C; Zárate A; Ruiz JE; Salazar LM
    Rev Invest Clin; 1983; 35(3):197-200. PubMed ID: 6314464
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience with placental site trophoblastic tumors at the New England Trophoblastic Disease Center.
    Finkler NJ; Berkowitz RS; Driscoll SG; Goldstein DP; Bernstein MR
    Obstet Gynecol; 1988 Jun; 71(6 Pt 1):854-7. PubMed ID: 2835717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.